Overview
Fedor Kryukov practices in Ostrava, Czech Republic. Mr. Kryukov is rated as an Advanced expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Primary Amyloidosis, and Waldenstrom Macroglobulinemia.
His clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaMr. Kryukov isAdvanced. Learn about Multiple Myeloma.
- Experienced
- LeukemiaMr. Kryukov isExperienced. Learn about Leukemia.
- Primary AmyloidosisMr. Kryukov isExperienced. Learn about Primary Amyloidosis.
- Waldenstrom MacroglobulinemiaMr. Kryukov isExperienced. Learn about Waldenstrom Macroglobulinemia.